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Purpose: Endoscopic resection is widely accepted as standard treatment for early gastric cancer (EGC) without lymph node metastasis. 
The procedure is minimally invasive, safe, and convenient. However, surgery is sometimes needed after endoscopic mucosal resection/
endoscopic submucosal dissection endoscopic mucosal resection (EMR)/endoscopic submucosal dissection (ESD) due to perforation, 
bleeding, or incomplete resection. We evaluated the role of surgery after incomplete resection.
Materials and Methods: We retrospectively studied 29 patients with gastric cancer who underwent a gastrectomy after incomplete EMR/
ESD from 2006 to 2010 at Korea University Hospital. 
Results: There were 13 incomplete resection cases, seven bleeding cases, three metachronous lesion cases, three recurrence cases, two 
perforation cases, and one lymphatic invasion case. Among the incomplete resection cases, a positive vertical margin was found in 10, a 
positive lateral margin in two, and a positive vertical and lateral margin in one case. Most cases (9/13) were diagnosed as mucosal tumors 
by endoscopic ultrasonography, but only three cases were confirmed as mucosal tumors on final pathology. The positive residual tumor rate 
was two of 13. The lymph node metastasis rate was three of 13. All lymph node metastasis cases were submucosal tumors with positive 
lymphatic invasion and no residual tumor in the gastrectomy specimen. No cases of recurrence were observed after curative resection.
Conclusions: A gastrectomy is required for patients with incomplete resection following EMR/ESD due to the risk of residual tumor and 
lymph node metastasis.
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Introduction
Early gastric cancer (EGC) is defined as a neoplasm confined 
to the mucosa or submucosa, regardless of regional lymph node 
metastasis.(1) EGC without evidence of nodal metastasis is treated 
by endoscopic resection, either endoscopic mucosal resection (EMR) 
or endoscopic submucosal dissection (ESD). The endoscopic 
method is widely accepted because it is less invasive and less costly 
and requires a shorter hospital stay than surgical resection.(2-4)
Guidelines for EMR/ESD, established by the Japanese Gastric 
Cancer Association, are generally accepted and state that: 1) el-
evated EGCs less than 2 cm in diameter and 2) small (≤1 cm) de-
pressed EGCs without ulceration are indications for EMR/ESD. At 
the same time, these lesions must be differentiated adenocarcinoma 
confined to the mucosa with no lymphatic or vascular involvement.(5)
The so-called extended criteria have been proposed to include: 
1) mucosal cancers without ulceration regardless of lesion size, 2) 
ulcerated mucosal cancers with a size restriction of 30 mm, and 3) 
cancers with minute submucosal invasion (＜500 μm) with a size 
restriction of 30 mm. Lesions with undifferentiated histology and 
lymphatic or vascular invasion are still excluded.(6,7)
Although endoscopic resection has the advantage of preserving Gastrectomy after Incomplete EMR/ESD
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most of the stomach and maintaining quality of life, some EMR/
ESD patients have incomplete resections.(8) In addition, EMR/ESD 
is associated with a complication frequency, particularly perforation 
and post-operative bleeding (delayed bleeding).(9) The risk of syn-
chronous and metachronous gastric cancer developing in the pa-
tient after endoscopic resection has also become a major problem.
(10) Incomplete resection patients are treated empirically, by either 
gastrectomy, additional endoscopic treatment, or careful follow-up.
(11)
We conducted this study to evaluate clinical outcomes and the 
role of surgery for patients with incomplete resection after EMR/
ESD.
Materials and Methods
We retrospectively evaluated 510 gastric cancer patients who 
underwent EMR/ESD for gastric neoplasm at Korea University 
Hospital from 2006 to 2010. From these patients, 482 patients with 
diagnosed gastric cancer were identified. We studied 29 gastric can-
cer patients who underwent gastrectomy following EMR/ESD. 
Incomplete resection was the most common cause of gastrec-
tomy (13 of 29 cases) following EMR/ESD. Thirteen patients who 
underwent gastrectomy after incomplete EMR/ESD was enrolled 
in the study. Indications for EMR in our hospital encompassed 
the extended criteria including mucosal cancers without ulceration 
regardless of lesion size, ulcerated mucosal cancers with a size re-
striction of 30 mm, and cancers with minute submucosal invasion 
with a size restriction of 30 mm. 
The EMR/ESD specimen was examined histopathologically. 
Resected specimens were systematically sectioned at 2-mm inter-
vals, centered on the part of the lesion closest to the margin and 
the site of deepest invasion. Incomplete resection was classified as a 
positive lateral margin, a positive vertical margin and both positive 
lateral and vertical margin. 
Results
1. Reasons for performing gastrectomy after EMR/ESD
The reasons for gastrectomy after EMR/ESD are shown in 
Table 1. There was bleeding in 7 cases, metachronous lesion in 3 
cases, recurrence in 3 cases, perforation in 2 cases, and lymphatic 
invasion 1 in case. Curative resection was performed in all patients. 
The surgeries performed were subtotal gastrectomy, B-I & B-II 
and total gastrectomy with Roux-en-Y esophagojejunostomy. 
Characteristics of the patients and the gastric lesions in incom-
Table 1. Reasons for performing gastrectomy aft  er EMR/ESD
Cause Case 
Incomplete resection  13 
Bleeding 7 
Metachronous lesion  3 
Recurrence 3 
Perforation 2 
Lymphatic invasion  1 
EMR = endoscopic mucosal resection; ESD = endoscopic submucosal 
dissection.
Table 2. Characteristics of the patients and the gastric lesions in 
incomplete cases (n=13)
Factor  
Number 
(N=13) 
% of 
patients  
Gender Male  7 53.8
Female  6 46.2
Age (years)   63.1±7.7 
Size <1  cm  1 7.7
≥1 cm, <2 cm  4 30.8
≥2 cm  8 61.5
Gross type   Elevated  4 30.8
Flat  4 30.8
Depressed  5 38.4
Location   Upper   2 15.4
Middle   2 15.4
Lower   9 69.2
Depth of invasion Mucosa 3 23.1
  (post-op) Submucosa 9 69.2
Muscle  1 7.7
LN metastasis  N0  10 76.9
N1  2 15.4
N2  0 0
N3  1 7.7
Final pathology  Well diff  erentiated 4 30.8
Moderately diff  erentiated 4 30.8
Poorly diff  erentiated 4 30.8
Signet ring cell carcinoma 1 7.7
Type of operation  RSG-BI 10 76.9
RSG-BII 1 7.7
Total gastrectomy 2 15.4
LN = lymph node; RSG = radical subtotal gastrectomy; B-I = Biloth-I; 
B-II = Biloth-II.Lee HJ, et al.
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plete cases (n=13). Of the 13 patients, 7 were male and 6 were 
female. The mean age of the patients was 63.1±7.7 years. There 
were 8 cases with lesion size greater than 2 cm.
After surgery, the depth of invasion was at the mucosa level in 
3 cases, at the submucosal level in 9 cases, and to the muscle in 1 
case. Three cases had LN metastases and 1 case was stage N3. 
In the final pathology, 8 cases (61.6%) were diagnosed as well or 
moderately differentiated adenocarcinoma. Four cases were poorly 
differentiated, and 1 case was diagnosed as signet ring cell carcino-
ma. The most common type of operation was subtotal gastrectomy 
with Billroth I anastomosis (Table 2).
2. Endoscopy, EMR/ESD and Operative findings 
9 of 13 cases were diagnosed as mucosal tumors on endoscopic 
ultrasonography (EUS) but only 3 cases were confirmed as mucosal 
tumors on final pathology. 
Three cases were diagnosed as tubular adenoma on endoscopy, 
with 1 case well differentiated and 2 cases moderately differentiat-
ed. Four cases were diagnosed as well differentiated on EMR/ESD 
with 1 case revised to moderately differentiated on final pathology 
(Table 3).
3. Relationship between positive margins with 
resi  dual tumors and lymph node metastasis
We analyzed the relationship between positive margins with 
residual tumors and lymph node metastasis. Positive residual tumor 
was present in 2 of 13 positive margin cases.
There was 1 case with lymph node metastasis in the positive 
lateral margin and 2 cases in the positive vertical margin (Table 4).
We also analyzed the relationship between depth of invasion 
with residual tumor and lymph node metastasis. One case with 
residual tumor had submucosal invasion and the other case had 
muscle invasion. All lymph node metastasis cases were submucosal 
tumors (Table 5). 
4. Cases of LN metastasis (n=3)
There were 3 cases of LN metastasis. The sizes were 1.5, 1.6, 
and 2.2 cm.
The histological results were moderately differentiated for case 1, 
and poorly differentiated in cases 2 and 3. All cases had submuco-
sal invasion. The number of LN metastases were 7, 2, and 1. 
Cases 1 and 3 had lymphatic invasions and no cases had vascu-
lar or neural invasions (Table 6). 
Table 3. Endoscopy, EMR/ESD and operative fi  ndings 
Endoscopy (EUS)  EMR/ESD Operation 
Depth of invasion  Mucosa  9 3 3
Submucosa 0 9 9
   SM 1  5
   SM 2 1
   SM 3  3
Muscle 0 1 1
Histology TA  3 0 0
WD 3 4 3
EMR = endoscopic mucosal resection; ESD = endoscopic submucosal dissection; EUS = endoscopic ultrasonography; TA = tubular adenoma; WD 
= adenocarcinoma, well diff  erentiated.
Table 4. Relationship between positive margins with residual tumors 
and lymph node metastasis
Group  Number  Residual tumor  LN metastasis 
LM    2 0 1
VM 10 1 2
LM+VM    1 1 0
LN = lymph node; LM = lateral margin; VM = vertical margin.
Table 5. Relationship between depth of invasion with residual tumor 
and lymph node metastasis 
Depth of invasion Number  Residual tumor LN metastasis
Mucosa 3 0 0
Submucosa 9 1 3
M u s c l e 110
LN = lymph node.Gastrectomy after Incomplete EMR/ESD
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Discussion
The role of surgery after incomplete EMR/ESD was has been 
previously reported. 
Song et al.(12) reported that gastrectomy with lymph node dis-
section should be performed in patients with submucosal invasion 
with or without margin involvement after EMR. 
Nagano et al.(13) reported that patients with submucosal inva-
sion or a positive vertical margin should undergo gastrectomy and 
lymph node dissection. 
At first, we expected that if the margin was positive, there’ll 
be residual tumor. But, the results were different. In our study, the 
positive residual tumor rate was only 15.4% (2 of 13) in positive lat-
eral and/or vertical margin cases. 84.6% (11 of 13) had no residual 
tumor despite positive margins. In the case that had both the lateral 
and vertical margins positive, there was no lymph node metastasis. 
In a recent study, Chang et al.(14) reported that in lesions in-
vading the lateral margin, the possibility of residual cancer was 
low.  This may be because the EMR/ESD specimen was not fully 
evaluated histologically. In addition, EMR/ESD is performed us-
ing a coagulating device which means that there might not be cells 
within the margin of the coagulated tissue. 
With regard to the depth of invasion, the presence of residual 
tumor was associated with submucosal and muscle invasion. In 
particular, the muscle invasion case required EMR with piecemeal 
dissection.
All lymph node metastasis cases were associated with submuco-
sal tumor. There was no lymph node metastasis in tumors confined 
to the mucosa.
These results suggest that the depth of invasion deserves greater 
consideration than positive margin status as an indication for sur-
gery after incomplete EMR/ESD. 
Recently there have been a few report regarding extended crite-
ria for EMR/ESD, it is significant especially regarding the applica-
tion of extended criteria its presence. 
The indications for EMR/ESD in our hospital used the ex-
tended criteria. There are some concerns regarding the application 
of extended criteria for EMR/ESD. 
Existing methods for preoperative detection of lymph node 
metastasis are not sufficiently accurate. The only reliable diagnos-
tic method for lymph node metastasis is pathological examination 
after lymph node dissection.(15,16) Therefore, EMR/ESD may 
miss lymph node metastases.(17) Our study showed lymph node 
metastasis in 3 of 13 (23.1%) cases that met the extended indication 
criteria. 
Ishikawa et al.(18) reported the relationship between lymph 
node metastasis and the tumor depth of wall invasion. When the 
depth of invasion was submucosal (＜500 μm), 2/15 (13%) of EGC 
differentiated type without ulcer had lymph node metastasis. The 
authors suggested that indications for EMR/ESD should be limited 
to mucosal tumors. In our study, all lymph node metastasis cases 
were submucosal tumors. Extending the indications for EMR/ESD 
remains controversial, and the applicability of the extended criteria 
should be further evaluated.
The invasion of tumor can be assessed by performing EUS. The 
accuracy of EUS for gastric cancer from different authors ranges 
from 64.8%(19) to 92%(20) in T staging and 50%(21) to 90%(22) in 
N staging. Currently, EUS is the most reliable method in T and N 
staging of gastric cancer with high accuracy rates.(23)
In our results, 9 of 13 cases were diagnosed as mucosal tumors 
on EUS but only 3 cases were confirmed as mucosal tumors on 
final pathology. More accurate pretreatment staging by EUS should 
be undertaken for proper stage-dependent patient management.
In conclusion, the gastrectomy is needed for patients with in-
complete resection after EMR/ESD, because of the risk of both 
residual tumor and lymph node metastasis. Precise T staging is es-
sential to avoid unnecessary procedures.
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